An insurer can define a target market correctly and still lose control when product information passes through a broker, comparison journey, appointed representative or embedded partner. The UK implemented the Insurance Distribution Directive in 2018, and the FCA moved relevant retained-EU provisions into its own rules from 5 April 2024. The practical obligation is not a historical “IDD project”: manufacturers and distributors must understand their roles, exchange enough reliable information, assess product and distribution arrangements, and ensure the proposed contract is consistent with the individual customer’s demands and needs. That creates a focused first purchase: an audit of one product through one live distribution chain, from governance record to customer outcome. This reading explains how an insurance, compliance or distribution specialist can package that audit, separate target-market design from the point-of-sale demands-and-needs test, locate missing management information and build recurring assurance without claiming that documentation alone proves fair value, suitability or compliance.
What did IDD change in UK insurance distribution?
IDD broadened and strengthened requirements across insurance distribution, including professional standards, conduct, information, product governance, conflicts and demands and needs. In the UK, firms complied from 1 October 2018. The current control framework now sits primarily in FCA rules and guidance rather than in a one-off implementation document.
The audit must therefore use the live FCA Handbook and the product’s current distribution model. A 2018 policy may explain history, but it cannot prove that today’s partners, customer groups or value assessment are controlled.
- 1Manufacturer and product approval
- 2Target market and distribution strategy
- 3Distributor information and training
- 4Customer demands and needs
- 5Sale, service, claim and review evidence
What changed when retained-EU provisions were replaced in 2024?
From 5 April 2024, FCA rules and guidance replaced relevant retained-EU delegated provisions while maintaining the insurance-distribution regime. Firms should map their procedures to the current Handbook and remove broken cross-references, but the change did not erase product-governance, distributor-information or conduct responsibilities.
This creates a useful trigger for a document-to-operation reconciliation: which rule is cited, which control performs it, which data tests it and who owns remediation when the evidence disagrees?
- FCA requirement and scope
- Manufacturer or distributor responsibility
- Operating control and system owner
- Management information and customer evidence
- Review, escalation and corrective action
What should a paid distribution-chain audit deliver?
A paid audit should select one product and channel, map manufacturer and distributor responsibilities, test information exchange, sample customer journeys and identify decisions on target market, demands and needs, value or remediation. It should produce an owned correction sequence—not a generic compliance review across every product and intermediary.
The first purchase can run over two weeks where agreements, product records, scripts and journey data are accessible. Specialist legal or actuarial questions remain with the authorised firm and its advisers. The closing decision should identify affected customer cohorts, immediate control changes and any product or distribution question requiring formal governance approval.
How does target market differ from demands and needs?
The target market describes the customer group for whom a product is designed and how it should be distributed. The demands-and-needs test uses information from the individual customer before contract conclusion and requires the proposed contract to be consistent with those needs. One is product and channel governance; the other is a customer-level sale control.
They should connect without collapsing into each other. A customer may sit broadly inside the target market yet require a different product, cover level or no sale after the individual test.
Sampling should compare the questions asked with the product features that can materially change the customer decision: exclusions, limits, excess, duration, optional add-ons and service expectations. A generic declaration that “the product meets my needs” provides little assurance if those decision points remain invisible.
- Étape 1Target market: characteristics, objectives, exclusions and channel
- Étape 2Information bridge: product features, limits, price and intended value
- Étape 3Demands and needs: customer facts, complexity and proposed contract
- Étape 4Outcome evidence: sale, service, claim, cancellation and complaint
What information must move from manufacturer to distributor?
The distributor needs sufficient, adequate and reliable information to understand the product, identified target market, distribution strategy and relevant value assessment. The manufacturer needs distribution and outcome information capable of revealing drift or detriment. A product brochure alone rarely supports both directions of that control.
The evidence map names fields, frequency, owner and escalation threshold. It also identifies outsourced platforms or data aggregators that transform information before either party sees it.
Information quality matters in both directions. Manufacturers need enough outcome evidence to review the product and channel; distributors need timely product changes and clear target-market boundaries. The audit should show when data arrives too late to influence a sale, renewal or corrective action.
Where does responsibility become ambiguous?
Responsibility becomes ambiguous when several firms shape the product or package, an intermediary changes the journey, an appointed representative controls the customer conversation, or no party owns poor-quality outcome data. Written agreements should describe roles, but the audit must verify who actually decides, monitors and corrects each part of the chain.
| Decision | Evidence | Owner |
|---|---|---|
| Product and target market | approval and review record | manufacturer |
| Channel suitability | distribution strategy and partner due diligence | manufacturer and distributor |
| Customer demands and needs | question path and sale record | distributor |
| Value and outcome signal | MI and customer evidence | agreed chain owner |
| Corrective action | escalation and customer remedy | accountable firms |
Which signals reveal product or channel drift?
Drift can appear in sales outside the target market, weak demands-and-needs records, unexpected cancellations, low claim acceptance, complaints, duplicate cover, premium-finance friction or distributors unable to explain the product. No single metric proves detriment, but patterns should trigger investigation and corrective action.
The audit chooses signals relevant to the product rather than importing an identical dashboard across motor, property, protection and commercial insurance.
Useful investigation starts with a defined hypothesis. A cancellation spike might indicate price, poor explanation, duplicate cover or a customer cohort outside the intended market. The team should test causes before changing the product or withdrawing a channel.
- Sales outside target market
- Early cancellation and lapse
- Claims acceptance and declined reasons
- Complaints and customer confusion
- Add-on, premium-finance and duplicate-cover friction
Which events create a credible buying window?
Buying intent rises before a product launch, after a new distributor or appointed representative joins, when an agreement changes, during value review, or after complaints and outcome data reveal inconsistency. A migration to new quoting or policy systems is another strong trigger because product information and customer questions may be altered.
Acquisition can combine insurer and broker partnerships, portfolio research, direct account outreach, specialist roundtables and search. Qualification confirms a product owner, channel access and the ability to obtain journey evidence.
- Detect outcome or information anomaly
- Identify product, channel and customer cohort
- Test cause and responsibility
- Correct journey, distribution or product
- Verify customer remedy and monitor recurrence
What recurring service follows the first audit?
The recurring service reviews product and channel changes, samples demands-and-needs evidence, monitors agreed outcome signals, tests information exchange and tracks corrective actions. Its cadence follows product risk and distribution change. It creates value by detecting drift early, not by repeating a static annual attestation.
When is an insurance-distribution campaign ready to launch?
The campaign is ready when the partner can trace one product through a real channel, distinguish manufacturer from distributor duties and turn evidence gaps into controlled decisions. GetFishNet’s free eligibility test checks target concentration, buying trigger, first-purchase value and recurring assurance capacity before acquisition channels are activated.
The strongest proposition is specific: one product, one channel, one set of customer signals. That focus makes responsibility visible and correction possible without pretending the entire distribution estate can be certified in one sprint.
Authorities cited: Financial Conduct Authority; UK Legislation. Dated references remain in the private source register.
The eligibility report dates and quantifies it, then tests whether it deserves action.
Reading the diagram. A disease contact only progresses after proof of origin, qualification of the relationship and control of the product concerned.
Text alternative. Telephone, prescriber or incoming request follow different proofs; missing consent causes documented exit.
How can the testing cycle reach a stable operating rhythm?
Relative benchmarks: D00 sets the rules of origin and termination of contact, D14 closes the preparation, W03 to W06 tests the scripts, consents, relationships of more than thirty-six months and ceilings per product, W07 to W08 arbitrator, then M03 stabilizes documented paths. Variances are recorded before any budget extension.
Gantt chart for the testing cycle — NON-EXHAUSTIVE DEMONSTRATION
Reading the diagram. The foundation secures the right to contact; exploration then measures the quality of requests before any channel stabilization.
Textual alternative. D00 sets consent, D14 audits scripts, W03–W06 tests provenance, W07–W08 cuts discrepancies, M03 maintains compliance.
What financial potential does the model make visible?
Model: 132 qualified conversations, 44 reviews and 26 new customers. Weighted average: 1 527 CHF; monthly total: 39 700 CHF. The projection concerns acquisitions agreed and allocated, without using the ceilings as margin or portfolio value. No national denominator is applied.
Breakdown of acquisitions — NON-EXHAUSTIVE DEMONSTRATION
The chart counts customers, not percentage points.
Reading the diagram. 26 acquisitions represent subscriptions preceded by a controlled origin and relationship; the size of a share does not prejudge either the documentary quality or the maintained value.
Text alternative. The circle distributes customers obtained after verifiable consent, never people simply called. Total: 26 customers, reread with the value specific to each channel.
How do customers, average monthly revenue, and recurring revenue correlate by channel?
| Channel explored | Customers | Average monthly revenue per customer | Monthly Recurring Channel Revenue |
|---|---|---|---|
| Natural and paid referencing | 4 | 1 300 CHF | 5 200 CHF |
| Telephone outreach | 3 | 1 600 CHF | 4 800 CHF |
| Voicemails | 2 | 900 CHF | 1 800 CHF |
| Email Campaigns | 4 | 1 200 CHF | 4 800 CHF |
| Social networks | 3 | 1 400 CHF | 4 200 CHF |
| Partners and prescribers | 3 | 2 000 CHF | 6 000 CHF |
| Events and webinars | 2 | 1 700 CHF | 3 400 CHF |
| Advertising retargeting | 1 | 1 100 CHF | 1 100 CHF |
| Strategic accounts and outbound outreach | 2 | 2 300 CHF | 4 600 CHF |
| Content and press relations | 2 | 1 900 CHF | 3 800 CHF |
| Total / weighted average | 26 | 1 527 CHF | 39 700 CHF |
The value is read again with the product, the applicable ceiling and the cost of controlling the provenance. The product customers × average income totals 39 700 CHF without promising performance.
Monthly recurring revenue by channel — NON-EXHAUSTIVE DEMONSTRATION
Reading the diagram. Compliant disease contacts, their converted volumes and the corresponding monthly income recompose 39 700 CHF without a value outside the table.
Alternative text. Each height associates an authorized channel, actual assigned customers, and the value specific to their product. Their addition exactly equals monthly 39 700 CHF.
How should acquisition cost be assessed before recurring revenue is scaled?
Arbitration adds proof of consent, script control, relationship data, call supervision and refusal handling and reports the charge to assigned customers. It compares legal origin, product concerned, ceiling, full cost, expected termination and service capacity then reduces any channel that weakens the proof.
Funnel to Retained Monthly Recurring Revenue — NON-EXHAUSTIVE DEMONSTRATION
Reading the diagram. disease contacts whose origin is demonstrated produce raw 39 700 CHF, then 34 142 CHF after maintaining at 86 %.
Text alternative. 132 conversations become 44 journals and 26 clients for disease contacts whose provenance is demonstrated. 39 700 CHF weighted to 86 % gives 34 142 CHF.
Financial limit. The 70 francs and the sixteen bonuses limit the remuneration; they give neither margin, nor number of contracts, nor maintenance. The 34 142 CHF remains a hypothesis, without reference value or forecast.
Which sources and related readings deepen this analysis?
Text references: Federal Office of Public Health, decision and rules applicable to intermediaries; monitoring activity report. The federal office describes ceilings and outreach, while consent and history remain evidence specific to the file. The addresses remain in the internal source register. Each topic retains a clear documentary boundary.
The ISA 2024 processes the status. The ICA 2022 processes the contract trace. The nLPD 2023 shows another prequalification of the contact and data.
CORRELATED READINGS — DYNAMIC MODULE
The thematic map will link rules 2024 of health insurance intermediaries to ISA for status, ICA for contract and nLPD for legality of contact data. The links remain governed without implying equivalence.
- See the insurance & brokerage market
- Explore all market readings
- Test the eligibility of your own window
The September deadline has passed; each origin of contact must always be able to be explained The report isolates the proof and the next action without reopening the 2024 rules of health insurance intermediaries.
The topic is broken down into entities, attributes, evidence, channels, costs and decision points. Institutions are cited in the text; no external resource interrupts the reading path.